Douglas Robinson

Group Lead, Advanced Biostatistical Sciences EMD Serono

Seminars

Tuesday 21st July 2026
The Fit-for-Purpose Clinical Outcome-Driven Tiered Cutoff Strategy in ctDNA & Beyond
11:30 am
  • Providing clarity on the necessary cutoff strategy for ctDNA, unsuring results are fit-for-purpose
  • Apply tiered threshold strategies that balance sensitivity and specificity depending on clinical decision points and disease context
  • Link biomarker cutoffs to meaningful clinical outcomes, strengthening regulatory confidence and enabling clearer clinical actionability
Douglas Robinson - Expert Speaker at the 5th Liquid Biopsy for Precision Oncology East Coast Summit